Navigation Links
Commentary suggests alternatives to routine use of OTC cold/cough meds in children
Date:4/30/2010

Alexandria, VA Despite their widespread use by parents and caregivers, over-the-counter (OTC) cold and cough medicines have carried a warning by the FDA since 2008, and still have the potential to cause serious adverse events in infants and children. Conservative therapies, including nasal suctioning, humidification, and nasal saline, should be recommended over routine use of OTC cough/cold products in infants and children, according to a new commentary published in the May 2010 issue of Otolaryngology Head and Neck Surgery.

According to the commentary, OTC cough/cold medications are commonly used in young children, to provide relief of symptoms of upper respiratory tract infections, including acute otitis media, the common cold, and rhinosinusitis. The Sloan Survey, a random telephone survey of medication use, reported on prescription and OTC medication use by 2,857 children under 12 years old, between 1998 and 2007 in the 48 contiguous United States. Among the commonly used medications were acetaminophen-pseudoephedrine, cold/fever medication (unspecified), dextromethorphan-pseudoephedrine, and cough medication (unspecified). The number of children given OTC medications was more than twice that of children given prescription medications in a given week.

"Parents may administer these products to children with good intentions, as they are medications that are widely used to treat adults with upper respiratory conditions," said commentary author David E. Tunkel, MD. "Data supporting their efficacy, however, do not exist. Evidence does exist of the potential for significant harm from use of these products in young children."

Pediatric otolaryngologists will often see children, physician-referred or self referred, for treatment of refractory upper respiratory tract infections. Some of these children will have been treated with cold/cough medications, and some of the parents will request such medications. The authors state that this presents otolaryngologists with a unique opportunity to educate patients and parents about this issue and to recommend treatment alternatives for home use.

The authors further state that recent regulatory changes have altered the labeled age indications for OTC cough/cold products, and this may change again in the future. Conservative measures such as humidification, analgesia, and irrigation should be considered as adjunctive treatment of upper respiratory infections, including the otitis media and sinusitis (acute or chronic), that physicians see in children. The authors urge continued study of the OTC medications to further examine the risk-benefit ratio they pose for infants and children.


'/>"/>

Contact: Jessica Mikulski
newsroom@entnet.org
703-535-3762
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

Related medicine news :

1. New commentary suggests alternatives to routine use of OTC cold/cough meds in children
2. Cinergy Health Commentary on House Healthcare Bill
3. Cinergy Health Commentary on Healthcare Summit
4. Global Health Defined as Public Health in a New Lancet Commentary by the Association of Schools of Public Health (ASPH)
5. Cinergy Health Commentary on Senate Healthcare Vote
6. Study Suggests How Some Cancers Resist Treatment
7. Mammograms May Not Boost Survival, Danish Study Suggests
8. Study suggests need for broader use of individualized learning plans for physicians
9. Gut Bacteria May Spur Obesity, Research Suggests
10. Study Suggests Low-Consuming Medicare Beneficiaries With Chronic Disease Are More Costly to Program
11. New study suggests stem cells sabotage their own DNA to produce new tissues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... This Saturday, January 28, the ... a very special performance by Alabama Symphony Orchestra musicians Yifan Zhou, Mara McClain & ... as dim sum, and exhibitors offer a look at Chinese games, crafts & more. ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a three-year ... and co-funded by the European Union (EU), was completed in May 2015. The future ... being maintained and used in air, which presents some challenges to establishing traceability to ...
(Date:1/24/2017)... ... January 24, 2017 , ... TopConsumerReviews.com recently gave a ... premenstrual syndrome, or PMS . , Most women of child-bearing age will experience ... constipation, irritability, headaches, fatigue, and other discomfort. For some women, the effects ...
(Date:1/24/2017)... , ... January 24, 2017 , ... “Mysteries Revealed On ... be a mysterious phenomenon is available to all Christians. “Mysteries Revealed On Speaking In ... of “U Beautiful Creation,” a Christian-based talk show located in Michigan. , “We ...
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and Medically ... the bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of Representatives. ... of Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks for ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... SPRINGFIELD GARDENS, N.Y. , Jan. 23, 2017 /PRNewswire/ ... an object from a blocked airway and prevented choking ... and disability awareness advocate to the LifeVac team as ... to have Steve join the LifeVac team," said ... is uniquely positioned to represent LifeVac and his mission ...
(Date:1/23/2017)... 23, 2017 7D Surgical announced today ... the U.S. Food and Drug Administration (FDA) and ... the North American commercial launch of its innovative ... surgery, the 7D Surgical System.  ... technologies and machine vision algorithms to eliminate the ...
(Date:1/23/2017)... -- Allergan plc, (NYSE: AGN ), a leading global ... Headache Academy (IHA). Designed to inspire a long-term commitment to ... a three-day, intensive overview on research and treatment options. This ... sponsor since the inception of IHA in North ... Europe in 2014. "Allergan is ...
Breaking Medicine Technology: